Technical Analysis for SBBP - Strongbridge Biopharma plc

Grade Last Price % Change Price Change
F 2.42 -2.02% -0.05
SBBP closed down 0.8 percent on Thursday, April 15, 2021, on 60 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical SBBP trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion -2.02%
Oversold Stochastic Weakness -2.02%
Stochastic Buy Signal Bullish -2.81%
Narrow Range Bar Range Contraction -2.81%
NR7 Range Contraction -2.81%
NR7-2 Range Contraction -2.81%
Wide Bands Range Expansion -2.81%
Oversold Stochastic Weakness -2.81%
Narrow Range Bar Range Contraction -2.81%
NR7 Range Contraction -2.81%
Older End-of-Day Signals for SBBP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 2 hours ago
Down 2 % about 3 hours ago
Down 1% about 3 hours ago
Fell Below Previous Day's Low about 3 hours ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Strongbridge Biopharma plc, a biopharmaceutical company, through its subsidiary, Cortendo AB (publ), develops, acquires, and commercializes product candidates that target rare diseases. The company's lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is in the Phase 3 trial for the treatment of endogenous Cushing's syndrome. It also has two product candidates, COR-004 and COR-005 in Phase 2 clinical development to treat acromegaly. In addition, it is developing BP-2001, a pre-clinical product candidate for the treatment of diabetes. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Clinical Development Organ Systems Diabetes Chemical Compounds Rare Diseases Chloroarenes Treatment Of Diabetes Acromegaly Cushing's Syndrome Adrenal Gland Disorders Piperazines Cortisol Endogenous Cushing's Syndrome

Is SBBP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.63
52 Week Low 1.87
Average Volume 1,227,976
200-Day Moving Average 2.92
50-Day Moving Average 3.02
20-Day Moving Average 2.77
10-Day Moving Average 2.64
Average True Range 0.20
ADX 15.99
+DI 20.01
-DI 19.20
Chandelier Exit (Long, 3 ATRs ) 3.22
Chandelier Exit (Short, 3 ATRs ) 3.03
Upper Bollinger Band 3.28
Lower Bollinger Band 2.27
Percent B (%b) 0.2
BandWidth 36.55
MACD Line -0.14
MACD Signal Line -0.11
MACD Histogram -0.0275
Fundamentals Value
Market Cap 166.09 Million
Num Shares 67.2 Million
EPS 0.62
Price-to-Earnings (P/E) Ratio 3.98
Price-to-Sales 5.27
Price-to-Book 2.44
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.62
Resistance 3 (R3) 2.63 2.58 2.60
Resistance 2 (R2) 2.58 2.55 2.58 2.59
Resistance 1 (R1) 2.53 2.52 2.51 2.52 2.58
Pivot Point 2.48 2.48 2.47 2.48 2.48
Support 1 (S1) 2.43 2.45 2.41 2.42 2.36
Support 2 (S2) 2.38 2.42 2.38 2.35
Support 3 (S3) 2.33 2.38 2.35
Support 4 (S4) 2.32